Literature DB >> 11828389

Jet nebulization of PEI/DNA polyplexes: physical stability and in vitro gene delivery efficiency.

C Rudolph1, R H Müller, J Rosenecker.   

Abstract

BACKGROUND: Aerosol drug delivery currently represents the most acceptable and convenient delivery system for repeated drug application to the lungs. Although polyethyleneimine (PEI) has recently been demonstrated to mediate gene transfer successfully to mouse lungs via aerosol delivery, the effect of the jet nebulization process on the properties of PEI/DNA polyplexes has not yet been examined.
METHODS: PEI/DNA polyplexes were generated in several commonly used solvents, such as distilled water, HEPES buffered saline (HBS), and 5% glucose. The complex parameters, such as particle size, zeta potential, DNA integrity, and transfection efficiency, were examined before and after jet nebulization.
RESULTS: The complex parameters and the transfection efficiency were influenced by the solvent that was used for complex formulation and by the nebulization process itself. When polyplexes were formulated in HBS, the particle size, zeta potential, and DNA concentration were affected by the nebulization process and the transfection efficiency decreased dramatically. Polyplexes formulated in 5% glucose were less susceptible to the nebulization process, as indicated by only minor changes of the zeta potential and particle size when compared with HBS. The resulting transfecion efficiency was very low both before and after nebulization. Polyplexes formulated in distilled water had the most resistant behavior with the nebulization process. Zeta potential, particle size, and DNA integrity were influenced least of all by nebulization.
CONCLUSION: As a result, the transfection efficiency of PEI/DNA complexes remained constant throughout the nebulization process only when formulated in distilled water. These data suggest that distilled water represents the most appropriate solvent for polyplex formulation when delivered by jet nebulization. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11828389     DOI: 10.1002/jgm.225

Source DB:  PubMed          Journal:  J Gene Med        ISSN: 1099-498X            Impact factor:   4.565


  7 in total

1.  Nanoparticle deposition onto biofilms.

Authors:  J K Miller; R Neubig; C B Clemons; K L Kreider; J P Wilber; G W Young; A J Ditto; Y H Yun; A Milsted; H T Badawy; M J Panzner; W J Youngs; C L Cannon
Journal:  Ann Biomed Eng       Date:  2012-08-10       Impact factor: 3.934

2.  Delivery of pDNA Polyplexes to Bronchial and Alveolar Epithelial Cells Using a Mesh Nebulizer.

Authors:  Larissa Gomes Dos Reis; Maree Svolos; Lyn M Moir; Rima Jaber; Norbert Windhab; Paul M Young; Daniela Traini
Journal:  Pharm Res       Date:  2018-11-15       Impact factor: 4.200

3.  Modeling the response of a biofilm to silver-based antimicrobial.

Authors:  A E Stine; D Nassar; J K Miller; C B Clemons; J P Wilber; G W Young; Y H Yun; C L Cannon; J G Leid; W J Youngs; A Milsted
Journal:  Math Biosci       Date:  2013-04-27       Impact factor: 2.144

4.  Application of novel solid lipid nanoparticle (SLN)-gene vector formulations based on a dimeric HIV-1 TAT-peptide in vitro and in vivo.

Authors:  Carsten Rudolph; Ulrike Schillinger; Aurora Ortiz; Kerstin Tabatt; Christian Plank; Rainer H Müller; Joseph Rosenecker
Journal:  Pharm Res       Date:  2004-09       Impact factor: 4.200

5.  Systemic delivery of DNA or siRNA mediated by linear polyethylenimine (L-PEI) does not induce an inflammatory response.

Authors:  Marie-Elise Bonnet; Patrick Erbacher; Anne-Laure Bolcato-Bellemin
Journal:  Pharm Res       Date:  2008-08-16       Impact factor: 4.200

6.  Nebulisation of IVT mRNA Complexes for Intrapulmonary Administration.

Authors:  Sarah M Johler; Joanna Rejman; Shan Guan; Joseph Rosenecker
Journal:  PLoS One       Date:  2015-09-09       Impact factor: 3.240

7.  Effects of size and topology of DNA molecules on intracellular delivery with non-viral gene carriers.

Authors:  Charlie Yu Ming Hsu; Hasan Uludağ
Journal:  BMC Biotechnol       Date:  2008-02-29       Impact factor: 2.563

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.